Initial Workup and Treatment for Cough
Classify Cough Duration First
Begin by classifying the cough as acute (<3 weeks), subacute (3-8 weeks), or chronic (>8 weeks), as this fundamentally determines your diagnostic and therapeutic approach. 1, 2
Initial Assessment - Key Historical Elements
Obtain a focused history targeting these specific factors:
- ACE inhibitor use - discontinue immediately if present, as this is a common reversible cause 1, 2, 3
- Smoking status - counsel on cessation, as 90-94% of smokers experience cough resolution within the first year of quitting 3
- Signs of life-threatening disease - assess for pneumonia, pulmonary embolism, or systemic illness requiring urgent intervention 1, 2
- Respiratory distress indicators - markedly elevated respiratory rate, intercostal retractions, cyanosis, or altered mental status 2
- Risk factors for complications - comorbidities, frailty, immunosuppression, or impaired cough clearance 2
Initial Diagnostic Testing
- Chest radiograph - obtain if pneumonia is suspected based on tachypnea, tachycardia, dyspnea, or abnormal lung findings 2
- Spirometry - perform as part of basic evaluation for chronic cough 4, 5
- Additional baseline tests for chronic cough: exhaled nitric oxide, blood eosinophil count, and validated cough severity/quality of life instruments 5
Management Based on Duration
Acute Cough (<3 weeks)
- For common cold: First-generation antihistamine/decongestant combination plus naproxen 2
- For acute exacerbation of chronic bronchitis: Short course (10-15 days) of systemic corticosteroids 2
- Avoid newer non-sedating antihistamines - they are ineffective for cough 2
Subacute Cough (3-8 weeks)
- Determine if postinfectious or non-infectious 1, 6
- For postinfectious cough: Consider upper airway cough syndrome (UACS), transient bronchial hyperresponsiveness, asthma, or pertussis 1, 6
- If non-infectious: Manage as chronic cough 1, 6
Chronic Cough (>8 weeks)
Use a sequential and additive treatment approach targeting the three most common causes, as multiple etiologies frequently coexist. 1, 2
Step 1: Upper Airway Cough Syndrome (UACS)
- Initial empiric treatment: Oral first-generation antihistamine/decongestant combination 1, 2, 6
- If prominent upper airway symptoms: Add topical corticosteroid 1
Step 2: Asthma
- If spirometry shows reversible airflow obstruction: Treat with inhaled bronchodilators and inhaled corticosteroids 2, 6
- If spirometry is normal: Perform bronchoprovocation challenge (BPC) when available 1
- If BPC unavailable: Empiric trial of inhaled corticosteroids and bronchodilators 1, 6
- For refractory cases: Add leukotriene receptor antagonist before escalating to oral corticosteroids 2
Step 3: Non-Asthmatic Eosinophilic Bronchitis (NAEB)
- Perform induced sputum test for eosinophils - this has important treatment implications and should be available in cough clinics 1
- If testing unavailable: Empiric trial of inhaled corticosteroids 1, 6
- Demonstration of sputum eosinophilia guides corticosteroid therapy 1
Step 4: Gastroesophageal Reflux Disease (GERD)
- Initiate empiric treatment for patients with typical reflux symptoms before performing esophageal testing 1
- No current esophageal function test predicts treatment response 1
When to Pursue Advanced Testing
If cough persists after 4-6 weeks of empiric treatment for the top diagnoses:
- High-resolution CT scan 1, 2, 5
- Bronchoscopic evaluation 1, 2
- Consider uncommon causes - including drug-induced cough, airway foreign body, tuberculosis (in high-prevalence areas), or other pulmonary/extrapulmonary causes 1, 2
- Referral to specialist cough clinic - recommended when diagnosis remains unclear 1
Critical Pitfalls to Avoid
- Do not rely on cough characteristics alone - they have little diagnostic value 1, 2
- Do not treat only one cause - multiple factors often contribute simultaneously, requiring additive therapy 1, 2
- Do not label as idiopathic until thorough assessment at a specialist clinic excludes uncommon causes 1
- Do not use routine cough suppressants when cough clearance is important 1
Special Populations
Immunocompromised Patients
- Use the same initial algorithm but expand differential diagnosis based on immune defect type and severity 1, 2
- In HIV patients with CD4+ <200 cells/μL: Suspect Pneumocystis pneumonia, tuberculosis, and opportunistic infections 1, 2